camostat has been researched along with Shock, Septic in 1 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tumurkhuu, G | 1 |
| Koide, N | 1 |
| Hiwasa, T | 1 |
| Ookoshi, M | 1 |
| Dagvadorj, J | 1 |
| Iftakhar-E-Khuda, I | 1 |
| Naiki, Y | 1 |
| Komatsu, T | 1 |
| Yoshida, T | 1 |
| Yokochi, T | 1 |
1 other study available for camostat and Shock, Septic
| Article | Year |
|---|---|
ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.
Topics: Allylglycine; Animals; Benzamidines; Cell Line, Tumor; Culture Media, Conditioned; Esters; Female; G | 2011 |